Skip to Content

Vitrolife AB ADR VTRLY

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Vitrolife AB is a medical device company. It develops, produces, and markets products for creating, prolonging, and improving life. The company's geographical segment includes EMEA, North and South America, Japan and Pacific and Asia. It derives a majority of revenue from the EMEA region. The company's product categories include Oocyte retrieval Needles; Sperm processing; IVF media and oil; Micromanipulation pipettes; Labware; Benchtop incubators; Time-lapse systems; Preimplantation Genetic Testing (PGT); Cryopreservation; Laser and imaging systems and Lab QC systems.

Box 9080
Gothenburg, 400 92, Sweden
T +46 317218000
Sector Healthcare
Industry Medical Devices
Most Recent Earnings Jun 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type
Employees 405